273 related articles for article (PubMed ID: 14737944)
21. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study.
Bakkevold KE; Kambestad B
Eur J Surg Oncol; 1993 Apr; 19(2):147-61. PubMed ID: 7684003
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
25. Radiation therapy, bypass operation and celiac plexus block in patients with unresectable locally advanced pancreatic cancer.
Yamaguchi K; Kobayashi K; Ogura Y; Nakamura K; Nakano K; Mizumoto K; Tanaka M
Hepatogastroenterology; 2005; 52(65):1605-12. PubMed ID: 16201126
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic cancer: management and survival.
Wakeman CJ; Martin IG; Robertson RW; Dobbs BR; Frizelle FA
ANZ J Surg; 2004 Nov; 74(11):941-4. PubMed ID: 15550079
[TBL] [Abstract][Full Text] [Related]
27. A twenty-year experience with adenocarcinoma of the anal canal.
Chang GJ; Gonzalez RJ; Skibber JM; Eng C; Das P; Rodriguez-Bigas MA
Dis Colon Rectum; 2009 Aug; 52(8):1375-80. PubMed ID: 19617747
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
[TBL] [Abstract][Full Text] [Related]
29. [Influence of adjuvant therapy on survival of patients with pancreatic carcinoma of body and tail: a report of 137 cases].
Xie YB; Wang CF; Li CR; Shan Y; Zhao DB; Tian YT; Zhao P
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(14):951-4. PubMed ID: 19671304
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.
Maire F; Hammel P; Ponsot P; Aubert A; O'Toole D; Hentic O; Levy P; Ruszniewski P
Am J Gastroenterol; 2006 Apr; 101(4):735-42. PubMed ID: 16635221
[TBL] [Abstract][Full Text] [Related]
31. [Non surgical treatment of pancreatic cancers].
Bleiberg H; Gerard B; Hendlisz A; Jagodzinski R
J Chir (Paris); 1997 Sep; 134(4):169-73. PubMed ID: 9499945
[TBL] [Abstract][Full Text] [Related]
32. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Thomas PR
Hepatogastroenterology; 1998; 45(21):610-2. PubMed ID: 9684105
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
36. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
[TBL] [Abstract][Full Text] [Related]
37. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses.
Schniewind B; Bestmann B; Kurdow R; Tepel J; Henne-Bruns D; Faendrich F; Kremer B; Kuechler T
Ann Surg Oncol; 2006 Nov; 13(11):1403-11. PubMed ID: 17009141
[TBL] [Abstract][Full Text] [Related]
38. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
39. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
40. Locoregional chemotherapy in pancreatic cancer.
Nazli O; Tansug T; Bozdag AD; Cln N; Kaymak E
Hepatogastroenterology; 1999; 46(25):479-82. PubMed ID: 10228847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
